IP Library Assignment 035469/0260
Patent Assignment
Reel/Frame 035469/0260

Merger

Recorded: 2015-04-22 Pages: 3
Assignor
IRM LLC
Executed: 2015-01-05
Assignee
NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.
131 FRONT STREET, HAMILTON, HM 12, BERMUDA
Covered Properties (36)
Compounds and Compositions for the Treatment of Parasitic Diseases
Compounds and Compositions for the Treatment of Parasitic Diseases
Antibody Drug Conjugates
Compounds and Compositions for the Treatment of Parasitic Diseases
Bioconjugates of Synthetic Apelin Polypeptides
Bis-Aromatic Alkanols
Patent: 7,169,817 →
Application: 10/445,967 →
Publication: US 2004/0048857
2, 4-Pyrimidinediamines Useful in the Treatment of Neoplastic Diseases, Inflammatory and Immune System Disorders
Patent: 7,893,074 →
Application: 10/568,367 →
Publication: US 2008/0132504
Diarylamine-Containing Compounds and Compositions, and Their Use as Modulators of C-Kit Receptors
Patent: 7,514,447 →
Application: 11/535,455 →
Publication: US 2007/0149538
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 8,552,002 →
Application: 11/570,983 →
Publication: US 2009/0137804
Diarylamine-Containing Compounds and Compositions, and Their Use as Modulators of C-Kit Receptors
Patent: 7,563,894 →
Application: 11/932,945 →
Publication: US 2008/0167308
Diarylamine-Containing Compounds and Compositions, and Their Use as Modulators of C-Kit Receptors
Patent: 7,638,523 →
Application: 11/933,030 →
Publication: US 2009/0012094
Diarylamine-Containing Compounds and Compositions, and Their Use as Modulators of C-Kit Receptors
Patent: 7,592,349 →
Application: 11/933,056 →
Publication: US 2008/0139559
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 8,202,876 →
Application: 12/444,129 →
Publication: US 2010/0029605
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 8,242,260 →
Application: 12/862,418 →
Publication: US 2011/0052578
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 8,501,758 →
Application: 12/870,130 →
Publication: US 2011/0306625
Compounds and Compositions as Tlr Activity Modulators
Patent: 8,466,167 →
Application: 12/921,129 →
Publication: US 2011/0081365
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 8,592,432 →
Application: 12/936,199 →
Publication: US 2011/0135668
PCSK9 Antagonists
Patent: 8,710,192 →
Application: 12/965,743 →
Publication: US 2011/0142849
Fibroblast Growth Factor 21 Mutations
Patent: 9,023,791 →
Application: 13/296,343 →
Publication: US 2012/0129766
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 8,563,553 →
Application: 13/473,230 →
Publication: US 2012/0225899
Bicyclic Heterocycle Derivatives for the Treatment of Pulmonary Arterial Hypertension
Patent: 8,883,819 →
Application: 13/599,267 →
Publication: US 2013/0237519
Compounds and Compositions as Protein Kinase Inhibitors
Application: 13/617,733 →
Publication: US 2013/0012476
Dual Function Fibroblast Growth Factor 21 Proteins
Patent: 9,458,214 →
Application: 13/626,207 →
Publication: US 2013/0129724
Substituted Pyridines for Modulating the Wnt Signaling Pathway
Patent: 9,181,235 →
Application: 13/701,982 →
Publication: US 2013/0079328
Compounds and Compositions as Tlr Activity Modulators
Patent: 8,895,577 →
Application: 13/867,752 →
Publication: US 2013/0253002
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 9,314,464 →
Application: 13/931,111 →
Publication: US 2013/0296318
PCSK9 Antagonists
Application: 13/984,785 →
Publication: US 2013/0315927
Compounds and Compositions as Protein Kinase Inhibitors
Patent: 8,859,548 →
Application: 14/022,540 →
Publication: US 2014/0011825
Compounds and Compositions for the Treatment of Parasitic Diseases
Patent: 8,871,754 →
Application: 14/083,203 →
Publication: US 2014/0155367
Solid Forms of Bicyclic Heterocyclic Derivatives
Patent: 9,073,921 →
Application: 14/187,214 →
Publication: US 2014/0249177
Cell Proliferation Inhibitors and Conjugates Thereof
Patent: 9,498,540 →
Application: 14/208,493 →
Publication: US 2014/0322247
Lectin-Like Oxidized Ldl Receptor 1 Antibodies and Methods of Use
Patent: 9,512,222 →
Application: 14/307,515 →
Publication: US 2015/0004168
Bioconjugates of Synthetic Apelin Polypeptides
Patent: 9,340,582 →
Application: 14/336,290 →
Publication: US 2015/0030594
Compounds and Compositions for the Treatment of Parasitic Diseases
Application: 14/492,736 →
Publication: US 2015/0011522
Bicyclic Heterocycle Derivatives for the Treatment of Pulmonary Arterial Hypertension
Patent: 9,751,876 →
Application: 14/511,044 →
Publication: US 2015/0025059
Bioconjugates of Synthetic Apelin Polypeptides
Application: 62/015,848 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 22, 2003
From: PAN, SHIFENG; YI, FAN; GAO, WENQI; GRAY, NATHANANAEL
To: IRM, LLC
Reel/Frame 014303/0569 →
Assignment of Assignor's Interest Jan 29, 2007
From: MOLTENI, VALENTINA; LI, XIAOLIN; CHIANELLI, DONATELLA; LOREN, JON
To: IRM LLC
Reel/Frame 018817/0777 →
Assignment of Assignor's Interest Mar 12, 2007
From: FURET, PASCAL; GUAGNANO, VITO
To: NOVARTIS AG
Reel/Frame 018992/0873 →
Assignment of Assignor's Interest Jun 3, 2008
From: MOLTENI, VALENTINA; LI, XIAOLIN; CHIANELLI, DONATELLA; LOREN, JON
To: IRM LLC
Reel/Frame 021035/0071 →
Assignment of Assignor's Interest Jun 3, 2008
From: FURET, PASCAL; GUAGNANO, VITO
To: NOVARTIS AG
Reel/Frame 021035/0085 →
Assignment of Assignor's Interest Jun 4, 2008
From: MOLTENI, VALENTINA; LI, XIAOLIN; CHIANELLI, DONATELLA; LOREN, JON
To: IRM LLC
Reel/Frame 021045/0384 →
Assignment of Assignor's Interest Jun 4, 2008
From: MOLTENI, VALENTINA; LI, XIAOLIN; CHIANELLI, DONATELLA; LOREN, JON
To: IRM LLC
Reel/Frame 021045/0006 →
Assignment of Assignor's Interest Jun 4, 2008
From: FURET, PASCAL; GUAGNANO, VITO
To: NOVARTIS AG
Reel/Frame 021044/0987 →
Assignment of Assignor's Interest Jun 4, 2008
From: FURET, PASCAL; GUAGNANO, VITO
To: NOVARTIS AG
Reel/Frame 021045/0405 →
Assignment of Assignor's Interest Jun 3, 2009
From: POON, DANIEL; RENHOWE, PAUL; SENDZIK, MARTIN
To: NOVARTIS AG
Reel/Frame 022777/0531 →
Assignment of Assignor's Interest Jun 3, 2009
From: ALBAUGH, PAMELA; CHOPIUK, GREGORY; DING, QIANG; HUANG, SHENLIN
To: IRM LLC
Reel/Frame 022777/0512 →
Assignment of Assignor's Interest Nov 3, 2009
From: MOLTENI, VALENTINA; LI, XIAOLIN; CHIANELLI, DONATELLA; LOREN, JON
To: IRM LLC
Reel/Frame 023464/0780 →
Assignment of Assignor's Interest Nov 3, 2009
From: FURET, PASCAL; GUAGNANO, VITO
To: NOVARTIS AG
Reel/Frame 023464/0880 →
Assignment of Assignor's Interest Aug 11, 2010
From: GARCIA-ECHEVERRIA, CARLOS; KANAZAWA, TAKANORI; KAWAHARA, EIJI; MASUYA, KEIICHI
To: NOVARTIS AG
Reel/Frame 024825/0828 →
Assignment of Assignor's Interest Oct 13, 2010
From: CORTEZ, ALEX; LI, YONGKAI; WU, TOM YAO-HSIANG; WU, XU
To: IRM LLC
Reel/Frame 025133/0953 →
Assignment of Assignor's Interest Oct 14, 2010
From: CORTEZ, ALEX; LI, YONGKAI; MISHRA, PRANAB; WU, TOM YAO-HSIANG
To: IRM LLC
Reel/Frame 025139/0060 →
Assignment of Assignor's Interest Nov 17, 2010
From: HUANG, SHENLIN; LIU, ZUOSHENG; TELLEW, JOHN
To: IRM LLC
Reel/Frame 025384/0204 →
Assignment of Assignor's Interest Nov 17, 2010
From: IRM LLC
To: NOVARTIS AG
Reel/Frame 026060/0256 →
Assignment of Assignor's Interest Nov 17, 2010
From: COSTALES, ABRAN Q.; JIN, JEFF XIANMING; PECCHI, SABINA; POON, DANIEL
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 025383/0842 →
Assignment of Assignor's Interest Nov 17, 2010
From: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
To: NOVARTIS AG
Reel/Frame 025383/0992 →
Assignment of Assignor's Interest Feb 14, 2011
From: HUANG, SHENLIN; LIU, ZUOSHENG; TELLEW, JOHN; WAN, YONGQIN
To: IRM LLC, A DELAWARE LIMITED LIABILITY CORPORATION
Reel/Frame 025803/0122 →
Assignment of Assignor's Interest Feb 14, 2011
From: JIN, XIANMING; POON, DANIEL
To: NOVARTIS AG
Reel/Frame 025803/0208 →
Assignment of Assignor's Interest Feb 22, 2011
From: RUE, SARAH; COHEN, STEVEN B.; LI, JUN
To: IRM LLC, A DELAWARE LIMITED LIABILITY CORPORATION
Reel/Frame 025844/0276 →
Assignment of Assignor's Interest Mar 2, 2011
From: SUZHOU NOVARTIS PHARMA TECHNOLOGY CO., LTD.
To: NOVARTIS AG
Reel/Frame 025890/0781 →
Assignment of Assignor's Interest Mar 2, 2011
From: GAO, ZHAOBO; GE, YONGHUI; HUANG, CHEN; LI, YUNCHENG
To: SUZHOU NOVARTIS PHARMA TECHNOLOGY CO., LTD.
Reel/Frame 025890/0713 →